Literature DB >> 29545356

Comparison of epidemiology, treatments and outcomes of ST segment elevation myocardial infarction between young and elderly patients.

Pin Pin Pek1, Huili Zheng2, Andrew Fu Wah Ho3, Win Wah4, Huay Cheem Tan5, Ling Li Foo2, Marcus Eng Hock Ong1,6.   

Abstract

BACKGROUND: With an ageing population, there is a need to understand the relative risk/benefit of interventions for elderly ST segment elevation myocardial infarction (STEMI) patients. The primary aim of this study was to compare epidemiology, treatments and outcomes between young and elderly STEMI patients. Our secondary aim was to determine the cut-off age when the benefits of primary percutaneous coronary intervention (PCI) were less pronounced.
METHODS: Data were collected by the Singapore Myocardial Infarction Registry. Patients were categorised into young (age <65 years) and elderly STEMI (age ≥65 years) patients.
RESULTS: We analysed 14 006 STEMI cases collected between January 2007 and December 2014; 33.9% were elderly STEMI patients. Elderly STEMI patients had longer median door to balloon (73 vs 64 min, P<0.001) time and were less likely to receive PCI (proportion difference=-23.6%, 95% CI -25.3 to -22.0). In the absence of PCI, elderly STEMI patients had a higher mortality within 30 days (elderly: HR 1.65, 95% CI 1.36 to 1.99, P<0.001; young: HR 1.10, 95% CI 0.79 to 1.54, P=0.573) and 1 year (elderly: HR 1.83, 95% CI 1.57 to 2.14, P<0.001; young: HR 1.41, 95% CI 1.09 to 1.83, P=0.009) of admission. The 1 year survival benefit of PCI started to decline after the age of 65 years.
CONCLUSION: Elderly STEMI patients were less likely to receive PCI and had longer door to balloon times. Survival benefit of PCI decreased after the age of 65 years, with the decline most evident from age 85 years onwards. The risks of PCI need to be weighed carefully against its benefits, especially in very elderly patients. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  acute myocardial infarct; aged; cardiac care, acute coronary syndrome; treatment

Mesh:

Year:  2018        PMID: 29545356     DOI: 10.1136/emermed-2017-206754

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  4 in total

1.  Combined assessment of frailty and nutritional status can be a prognostic indicator after percutaneous coronary intervention.

Authors:  Ryota Noike; Hideo Amano; Shojiro Hirano; Masakazu Tsubono; Yoshimasa Kojima; Yosuke Oka; Hiroto Aikawa; Shingo Matsumoto; Takayuki Yabe; Takanori Ikeda
Journal:  Heart Vessels       Date:  2022-09-28       Impact factor: 1.814

2.  Final benefit of primary percutaneous coronary intervention for ST-elevation myocardial infarction in older patients: long-term results of a randomised trial.

Authors:  M-J de Boer; J P Ottervanger; A W J Van't Hof; J C A Hoorntje; H Suryapranata; F Zijlstra
Journal:  Neth Heart J       Date:  2022-09-16       Impact factor: 2.854

3.  Characteristics and outcomes of young patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: retrospective analysis in a multiethnic Asian population.

Authors:  Benjamin Wl Tung; Zhe Yan Ng; William Kristanto; Kalyar Win Saw; Siew-Pang Chan; Winnie Sia; Koo Hui Chan; Mark Chan; William Kong; Ronald Lee; Joshua P Loh; Adrian F Low; Kian Keong Poh; Edgar Tay; Huay Cheem Tan; Tiong-Cheng Yeo; Poay Huan Loh
Journal:  Open Heart       Date:  2021-01

4.  Impact of STEMI Diagnosis and Catheterization Laboratory Activation Systems on Sex- and Age-Based Differences in Treatment Delay.

Authors:  Christine Pacheco; Laurie-Anne Boivin-Proulx; Alexandra Bastiany; Alexis Matteau; Samer Mansour; François Gobeil; Oana-Maria Simion; André Kokis; C Noel Bairey Merz; Brian J Potter
Journal:  CJC Open       Date:  2021-01-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.